Melanoma and the Hippo pathway

Project Description

Discovering new treatments for different types of human cancer is essential. We have identified the Hippo tumor suppressor signaling pathway as a potential new avenue by which melanoma, the deadliest form of skin cancer, could be treated. Using highly efficient laboratory modelling of human melanoma, we will test whether targeting the Hippo pathway could treat this disease. Our findings will have the potential to influence treatment of other cancers too.

Lay report

Year

2015-2017

Researchers

Dr Mark Shackleton, A/Prof Kieran Harvey

Funding Body

Cancer Council Research Grant

Institution

Research Division, Peter MacCallum Cancer Centre

Funding

$100,000 per annum

Updated: